{
    "organizations": [],
    "uuid": "fbb2eca77612c35f52e036d567729744edb7a950",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-mei-pharma-announces-fda-clearance/brief-mei-pharma-announces-fda-clearance-of-investigational-new-drug-application-for-cdk-inhibitor-voruciclib-idUSASB0C04V",
    "ord_in_thread": 0,
    "title": "BRIEF-MEI Pharma Announces FDA Clearance Of Investigational New Drug Application For CDK Inhibitor Voruciclib",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - MEI Pharma Inc:\n* MEI PHARMA ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR CDK INHIBITOR VORUCICLIB\n* MEI PHARMA INC - LOOK FORWARD TO ADVANCING VORUCICLIB THROUGH CLINIC IN Q2 OF 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-08T22:13:00.000+02:00",
    "crawled": "2018-01-09T16:50:34.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "mei",
        "pharma",
        "inc",
        "mei",
        "pharma",
        "announces",
        "fda",
        "clearance",
        "investigational",
        "new",
        "drug",
        "application",
        "cdk",
        "inhibitor",
        "voruciclib",
        "mei",
        "pharma",
        "inc",
        "look",
        "forward",
        "advancing",
        "voruciclib",
        "clinic",
        "q2",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}